Enhancing Anticancer Treatment Efficacy With Lycopene: A Comprehensive Review of...

연구 요약

Enhancing Anticancer Treatment Efficacy With Lycopene: A Comprehensive Review of Clinical and Preclinical Evidence.

Journal of biochemical and molecular toxicology 학술지에 발표된 이 연구는 Vishwa R, Sailo BL, BharathwajChetty B 외 연구팀이 수행하였습니다.

이 연구는 'Enhancing Anticancer Treatment Efficacy With Lycopene: A Comprehensive Review of Clinical and Preclinical Evidence.'에 대한 과학적 분석을 제공합니다.

핵심 내용

Lycopene (LYP), the red pigment found in tomatoes, is a non-provitamin A carotenoid recognized for its biological significance and anticancer potential. Beyond its direct anticancer effects, LYP has been shown to enhance the efficacy of various anticancer agents when used in combination. Herein, we have conducted a literature survey using PubMed and ClinicalTrials.gov databases, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, to systematically review LYP's efficacy in combination therapy. A search in PubMed using the keywords "lycopene and combination and cancer" yielded 206 studies, while "lycopene and cancer" retrieved 27 clinical trials from ClinicalTrial.gov. After applying the defined eligibility criteria, 45 relevant studies were included: 37 unique to PubMed, six unique to ClinicalTrials.gov, and two common to both databases. These studies collectively demonstrate that LYP, when used in combination with other therapeutic agents, can modulate several key oncogenic signaling pathways, including JAK2, MAPK, Akt/mTOR, IGF-1R, Akt/EZH2/AR, and PPARγ/LXRα/ABCA1. Additionally, LYP influences the activity of NF-κB, IFN-γ, and Nrf2, and also modulates cellular processes such as autophagy, apoptosis, and antioxidant defense mechanisms. These alterations have been observed when LYP is combined with various anticancer therapeutics, including radiation therapy, photodynamic therapy, standard chemotherapeutic agents such as cisplatin, 5-fluorouracil, taxanes, and sorafenib, as well as several phytochemicals and other potential anticancer agents, across various cancers. Nevertheless, robust clinical validation is required to confirm the therapeutic potential of these combinations and to establish LYP as an effective adjuvant in cancer treatment.

일반인을 위한 해석

구체적인 실천 사항은 담당 의사 또는 약사와 상담하시기 바랍니다.

실천 사항

• 현재 복용 중인 약물이나 영양제에 대해 궁금한 점이 있다면 담당 의사 또는 약사와 상담하시기 바랍니다
• 약물이나 영양제의 용법·용량을 임의로 변경하지 마세요
• 이상 반응이 나타나면 즉시 전문가에게 문의하세요

의사/약사의 전문적 판단을 대체하지 않습니다 (PMID: 41140031)